296 related articles for article (PubMed ID: 17102900)
1. 3rd College of Physicians' lecture--translational research: From bench to bedside and from bedside to bench; incorporating a clinical research journey in IgA nephritis (1976 to 2006).
Woo KT; Lau YK; Yap HK; Lee GS; Choong HL; Vathsala A; Chiang GS; Lee EJ; Wong KS; Lim CH
Ann Acad Med Singap; 2006 Oct; 35(10):735-41. PubMed ID: 17102900
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme inhibitor versus angiotensin 2 receptor antagonist therapy and the influence of angiotensin-converting enzyme gene polymorphism in IgA nephritis.
Woo KT; Lau YK; Chan CM; Wong KS
Ann Acad Med Singap; 2008 May; 37(5):372-6. PubMed ID: 18536822
[TBL] [Abstract][Full Text] [Related]
3. Disease progression, response to ACEI/ATRA therapy and influence of ACE gene in IgA nephritis.
Woo KT; Lau YK; Zhao Y; Liu FE; Tan HB; Tan EK; Stephanie FC; Chan CM; Wong KS
Cell Mol Immunol; 2007 Jun; 4(3):227-32. PubMed ID: 17601378
[TBL] [Abstract][Full Text] [Related]
4. Proteinuria and angiotensin converting enzyme (ACE) gene polymorphism.
Woo KT; Lau YK
Ann Acad Med Singap; 2000 May; 29(3):383-7. PubMed ID: 10976394
[TBL] [Abstract][Full Text] [Related]
5. ACEI/ATRA therapy decreases proteinuria by improving glomerular permselectivity in IgA nephritis.
Woo KT; Lau YK; Wong KS; Chiang GS
Kidney Int; 2000 Dec; 58(6):2485-91. PubMed ID: 11115082
[TBL] [Abstract][Full Text] [Related]
6. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS
Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
[TBL] [Abstract][Full Text] [Related]
7. Deletion polymorphism of the angiotensin converting enzyme gene predicts persistent proteinuria in Henoch-Schönlein purpura nephritis.
Yoshioka T; Xu YX; Yoshida H; Shiraga H; Muraki T; Ito K
Arch Dis Child; 1998 Nov; 79(5):394-9. PubMed ID: 10193250
[TBL] [Abstract][Full Text] [Related]
8. The natural history of IgA nephritis in Singapore.
Woo KT; Edmondson RP; Wu AY; Chiang GS; Pwee HS; Lim CH
Clin Nephrol; 1986 Jan; 25(1):15-21. PubMed ID: 3955904
[TBL] [Abstract][Full Text] [Related]
9. ACE gene sequence and nucleotide variants in IgA nephropathy.
Woo KT; Lau YK; Chan CM; Zhao Y; Tan HB; Liu FE; Fook-Chong S; Wong KS
Singapore Med J; 2011 Nov; 52(11):824-34. PubMed ID: 22173253
[TBL] [Abstract][Full Text] [Related]
10. Glomerulonephritis in Singapore: an overview.
Woo KT; Chiang GS; Edmondson RP; Wu AY; Lee EJ; Pwee HS; Lim CH
Ann Acad Med Singap; 1986 Jan; 15(1):20-31. PubMed ID: 3707031
[TBL] [Abstract][Full Text] [Related]
11. Renin-angiotensin system gene polymorphisms: its impact on IgAN and its progression to end-stage renal failure among Chinese in Singapore.
Lau YK; Woo KT; Choong HL; Zhao Y; Tan HB; Chong SM; Tan EK; Yap HK; Wong KS
Nephron Physiol; 2004; 97(1):p1-8. PubMed ID: 15153745
[TBL] [Abstract][Full Text] [Related]
12. Proteinuria: clinical signficance and basis for therapy.
Woo KT; Lau YK
Singapore Med J; 2001 Aug; 42(8):385-9. PubMed ID: 11764058
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy.
Hunley TE; Julian BA; Phillips JA; Summar ML; Yoshida H; Horn RG; Brown NJ; Fogo A; Ichikawa I; Kon V
Kidney Int; 1996 Feb; 49(2):571-7. PubMed ID: 8821846
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme insertion/deletion polymorphism and prognosis of IgA nephropathy.
Syrjänen J; Huang XH; Mustonen J; Koivula T; Lehtimäki T; Pasternack A
Nephron; 2000 Oct; 86(2):115-21. PubMed ID: 11014979
[TBL] [Abstract][Full Text] [Related]
15. IgA nephritis: a review of the pathogenetic mechanisms and the rationale for therapy.
Woo KT
Ann Acad Med Singap; 1989 Nov; 18(6):702-6. PubMed ID: 2560358
[TBL] [Abstract][Full Text] [Related]
16. Protein selectivity: a prognostic index in IgA nephritis.
Woo KT; Lau YK; Yap HK; Lee GS; Chiang GS; Lim CH
Nephron; 1989; 52(4):300-6. PubMed ID: 2770944
[TBL] [Abstract][Full Text] [Related]
17. Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy.
Yoshida H; Mitarai T; Kawamura T; Kitajima T; Miyazaki Y; Nagasawa R; Kawaguchi Y; Kubo H; Ichikawa I; Sakai O
J Clin Invest; 1995 Nov; 96(5):2162-9. PubMed ID: 7593601
[TBL] [Abstract][Full Text] [Related]
18. Influence of the endothelial nitric oxide synthase polymorphism on the progression of autosomal dominant polycystic kidney disease and IgA nephropathy.
Merta M; Reiterová J; Tesar V; Stekrová J; Viklický O
Ren Fail; 2002 Sep; 24(5):585-93. PubMed ID: 12380903
[TBL] [Abstract][Full Text] [Related]
19. Insertion/deletion polymorphism in ACE gene is not associated with renal progression in Japanese patients with IgA nephropathy.
Suzuki S; Suzuki Y; Kobayashi Y; Harada T; Kawamura T; Yoshida H; Tomino Y
Am J Kidney Dis; 2000 May; 35(5):896-903. PubMed ID: 10793025
[TBL] [Abstract][Full Text] [Related]
20. Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis.
Nakamura T; Obata J; Kimura H; Ohno S; Yoshida Y; Kawachi H; Shimizu F
Kidney Int; 1999 Mar; 55(3):877-89. PubMed ID: 10027924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
